SCHEMBL18308803

SCHEMBL18308803

Cc1ccc(-c2cccc(-c3ccc(P)cc3C)c2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 2/20 0.40
▸ ALDH1A1 P00352 1/20 0.40
▸ PGR P06401 1/20 0.38
▸ DHODH Q02127 1/20 0.38
▸ ALKBH3 Q96Q83 1/20 0.38
▸ ESR2 Q92731 2/20 0.37
▸ PTPN5 P54829 1/20 0.36
▸ ESR1 P03372 2/20 0.35
▸ MEN1 O00255 1/20 0.35
▸ KMT2A Q03164 1/20 0.35
▸ HSD17B1 P14061 1/20 0.35
▸ HSD17B2 P37059 1/20 0.35
▸ PDK2 Q15119 1/20 0.35
▸ HPRT1 P00492 1/20 0.34
▸ ENPP3 O14638 1/20 0.33
▸ AKR1C3 P42330 1/20 0.33
▸ AKR1C2 P52895 1/20 0.33
▸ ADORA3 P0DMS8 1/20 0.33
▸ ABL1 P00519 1/20 0.33
▸ ABCB1 P08183 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18308788 0.90 PGR (0.41) MAPTALDH1A1PGRDHODHALKBH3
SCHEMBL18308794 0.89 MAPT (0.39) MAPTPGRESR2ESR1MEN1
SCHEMBL18308791 0.87 ESR2 (0.38) ALDH1A1ESR2ESR1MEN1KMT2A
SCHEMBL18308734 0.85 ESR2 (0.39) MAPTALDH1A1ESR2ESR1MEN1
SCHEMBL18308810 0.84 HTR7 (0.35) MAPTPGRESR2ESR1MEN1
SCHEMBL18621839 0.83 DHODH (0.45) MAPTALDH1A1PGRDHODHALKBH3
SCHEMBL18308786 0.82 ESR2 (0.37) MAPTALDH1A1PGRALKBH3ESR2
SCHEMBL18411623 0.82 ESR2 (0.55) MAPTALDH1A1ESR2MEN1KMT2A
SCHEMBL18308763 0.82 ESR2 (0.37) MAPTALDH1A1PGRALKBH3ESR2
SCHEMBL18806012 0.81 ESR2 (0.33) ESR2ESR1AKR1C3AKR1C2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11718791-B2 Polymerisable compounds and the use thereof in liquid-crystal displays MERCK PATENT GMBH (DE) 2023-08-08 — — US disclosed
US-20170121606-A1 POLYMERIZABLE COMPOUNDS AND THE USE THEREOF IN LIQUID-CRYSTAL DISPLAYS GMBH, MERCK PATENT (DE) 2017-05-04 — — US disclosed
US-20160362606-A1 POLYMERIZABLE COMPOUNDS AND THE USE THEREOF IN LIQUID-CRYSTAL DISPLAYS MERCK PATENT GMBH (DE) 2016-12-15 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11718791-B2 Polymerisable compounds and the use thereof in liquid-crystal displays VCL, ILK, LCP1 MAPT 34/4885ALDH1A1 4572/4885PGR 3715/4885
US-20170121606-A1 POLYMERIZABLE COMPOUNDS AND THE USE THEREOF IN LIQUID-CRYSTAL DISPLAYS VCL, LCP1, MAP1LC3C MAPT 41/4885ALDH1A1 4590/4885PGR 3826/4885
US-20160362606-A1 POLYMERIZABLE COMPOUNDS AND THE USE THEREOF IN LIQUID-CRYSTAL DISPLAYS VCL, PLEC, EML4 MAPT 40/4885ALDH1A1 4429/4885PGR 3596/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback